References
- Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2009;247:289–302.
- Chu DS, Foster CS. Sympathetic ophthalmia. Int Ophthalmol Clin. 2002;42:179–185.
- Savar A, Andreoli MT, Kloek CE, Andreoli CM. Enucleation for open globe injury. Am J Ophthalmol. 2009;147:595–600.
- Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and republic of Ireland. Br J Ophthalmol. 2000;84:259–263.
- Kumar K, Mathai A, Murthy SI, et al. Sympathetic ophthalmia in pediatric age group: clinical features and challenges in management in a tertiary center in southern India. Ocul Immunol Inflamm. 2014;22:367–372.
- Manandhar A. Sympathetic ophthalmia: enucleation or evisceration? Nepal J Ophthalmol. 2011;3:181–187.
- Ramamurthi S, Cornish KS, Steeples L, Ramaesh K. Penetrating keratoplasty for the exciting eye in sympathetic ophthalmia. Cornea. 2008;27:1080–1081.
- Ganesh SK, Sundaram PM, Biswas J, Babu K. Cataract surgery in sympathetic ophthalmia. J Cataract Refract Surg. 2004;30:2371–2376.
- Gupta V, Gupta A, Dogra MR. Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India. Eye (Lond). 2008;22:1459–1464.
- Gupta V, Gupta A, Dogra MR. Reversible retinal changes in the acute stage of sympathetic ophthalmia as seen on spectral domain optical coherence tomography. Int Ophthalmol. 2011;31:105–110.
- Albert DM, Diaz RR. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol. 1989;34:1–14.
- Arevalo JF, Garcia RA, Al-Dhibi HA, Sanchez JG, Suarez-Tata L. Update on sympathetic ophthalmia. Middle East Afr J Ophthalmol. 2012;19:13–21.
- Jakabiec FA, Marboe CC, Knowles DM. Human sympathetic ophthalmia: ananalysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry and correlative electron microscopy. Ophthalmology. 1983;90:76–95.
- Henkind P, Wise GN. Cataract extraction in a sympathizing eye. Am J Ophthalmol. 1974;77:112–114.
- Ramamurthi S, Obi EE, Dutton GN, Ramaesh K. Management and clinical outcome of penetrating keratoplasty for long-term corneal changes in sympathetic ophthalmia. J Ophthalmol. 2011;5:1150–1155.
- Tessler HH, Jennings T. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet’s disease. Br J Ophthalmol. 1990;74:353–357.
- Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.
- Kempen JH, Daniel E, Dunn JP, Wessely S. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ. 2009;339:b2480.
- Ozbek Z, Arikan G, Yaman A, Oner H, Bajin MS, Saatci AO. Sympathetic ophthalmia following vitreoretinal surgery. Int Ophthalmol. 2010;30:221–227.
- Pollack AL, McDonald HR, Ai E, et al. Sympathetic ophthalmia associated with pars plana vitrectomy without antecedent penetrating trauma. Retina. 2001;21:146–154.